- Home
- PXLW vs CTSO Comparison
PXLW vs CTSO Comparison
Compare PXLW & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- CTSO
- Stock Information
- Founded
- PXLW 1997
- CTSO 1997
- Country
- PXLW United States
- CTSO United States
- Employees
- PXLW N/A
- CTSO N/A
- Industry
- PXLW Semiconductors
- CTSO Medical/Dental Instruments
- Sector
- PXLW Technology
- CTSO Health Care
- Exchange
- PXLW Nasdaq
- CTSO Nasdaq
- Market Cap
- PXLW 49.1M
- CTSO 51.6M
- IPO Year
- PXLW 2000
- CTSO N/A
- Fundamental
- Price
- PXLW $0.81
- CTSO $1.15
- Analyst Decision
- PXLW Strong Buy
- CTSO Strong Buy
- Analyst Count
- PXLW 3
- CTSO 3
- Target Price
- PXLW $2.17
- CTSO $4.67
- AVG Volume (30 Days)
- PXLW 349.9K
- CTSO 147.4K
- Earning Date
- PXLW 02-12-2025
- CTSO 03-06-2025
- Dividend Yield
- PXLW N/A
- CTSO N/A
- EPS Growth
- PXLW N/A
- CTSO N/A
- EPS
- PXLW N/A
- CTSO N/A
- Revenue
- PXLW $43,206,000.00
- CTSO $37,739,531.00
- Revenue This Year
- PXLW $10.25
- CTSO $9.20
- Revenue Next Year
- PXLW $39.19
- CTSO $11.64
- P/E Ratio
- PXLW N/A
- CTSO N/A
- Revenue Growth
- PXLW N/A
- CTSO 1.80
- 52 Week Low
- PXLW $0.61
- CTSO $0.70
- 52 Week High
- PXLW $3.08
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- PXLW 46.76
- CTSO 55.74
- Support Level
- PXLW $0.80
- CTSO $1.06
- Resistance Level
- PXLW $0.90
- CTSO $1.61
- Average True Range (ATR)
- PXLW 0.06
- CTSO 0.13
- MACD
- PXLW -0.01
- CTSO 0.01
- Stochastic Oscillator
- PXLW 11.96
- CTSO 29.34
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.